Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 14 October 2009, doi:10.1136/bmj.b4216
Cite this as: BMJ 2009;339:b4216
John Zarocostas
1 Geneva
| The first 150 words of the full text of this article appear below. |
About 100 low and middle income nations will start receiving the first deliveries of H1N1 flu vaccines donated by drug companies and governments as early as November, World Health Organization officials announced on 12 October. Healthcare workers have been designated the highest priority target group.
Marie-Paule Kieny, director of WHOs vaccine research initiative, told reporters, "The director general of WHO will approve, most likely today, a list of countries who will be the beneficiaries of these donations."
The countries on the WHO list currently dont have access to pandemic vaccine, said Dr Kieny. She said the agency is finalising guidelines for introducing the vaccine
"The principle for the deployment of the vaccine will be vulnerability: countries that are most vulnerable should receive the vaccine first. Then the second factor is readiness of a country to introduce a vaccine," she said.
Assessing vulnerability will take into account each countrys ratio of
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?